Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

NCT03867487 is registered in ClinicalTrials.gov with Justin Ryder as lead sponsor.

NCT NCT03867487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
Lead sponsor
Justin Ryder
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2027
Completion date
February 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, non-alcoholic fatty liver disease, pediatric nafld